DIALYSIS · CCN 072539

USRC Orange Dialysis

ORANGE, CT 06477

DialysisProfitUS Renal Care, Inc.
$8.9M
TOTAL REVENUE
18.1%
OPERATING MARGIN
4 / 5
STAR RATING
16
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$8.9M
Total costs
$7.3M
Operating income (rev − costs)
$1.6M
Operating margin
18.1%
Total charges
$8.9M
Total treatments
19,997
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

16 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
97114—
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
9934—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.57104—
Fistula Rate
DFC_FISTULA_RATE
63.6129—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.6170—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
137.1136—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
1150—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.33——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
18129—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
16.5577—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
30.5110—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
22.9138—
Standardized ED Visits Ratio
DFC_SEDR
0.4958—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
16.848—